Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma.
What is CAR T-cell therapy?
When the California Center for Rare Diseases at UCLA opens its doors, it will become a destination of hope for patients and their families who have struggled to find a diagnosis and treatment for [...]